Wipfli Financial Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Wipfli Financial Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Buy	+10	New	+$519	﹤0.01%	2583

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wipfli Financial Advisors's IHI Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in iShares US Medical Devices ETF (IHI) in Q3 2022: 10 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2583 among its holdings.

556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

Wipfli Financial Advisors held 10 shares of iShares US Medical Devices ETF worth $0 as of Q3 2022.
iShares US Medical Devices ETF was a new Wipfli Financial Advisors position in Q3 2022.
iShares US Medical Devices ETF made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2583 holding.
556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.